Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Masahiro Imamura, Yutaka Tsutsumi, Yoko Miura, Tomomi Toubai & Junji Tanaka. (2003) Immune Reconstitution and Tolerance after Allogeneic Hematopoietic Stem Cell Transplantation. Hematology 8:1, pages 19-26.
Read now
Read now
Articles from other publishers (22)
Jamshid Motaei, Mohammad Amin Kerachian, Seied Asadollah Mousavi, Kamran Alimoghadam, Ardeshir Ghavamzadeh, Saba Manoochehrabadi, Mohammad Ahmadvand & Marjan Yaghmaie. (2021) Circulating miR-455-3p, miR-5787, and miR-548a-3p as potential noninvasive biomarkers in the diagnosis of acute graft-versus-host disease: a validation study. Annals of Hematology 100:10, pages 2621-2631.
Crossref
Crossref
Raziyeh Tootoonchian, Fatemeh Pak, Ali M. Ardekani, Nasrin Sehati, Manuchehr Abedi-Valugerdi & Parviz Kokhaei. (2016) Evaluation of interleukin 12 and CD56+ lymphocyte cells in pediatric hematopoietic stem cell transplantation for early diagnosis of acute graft versus host disease. Transplant Immunology 39, pages 25-29.
Crossref
Crossref
Hui Wang & Yong‐Guang Yang. (2014) The complex and central role of interferon‐γ in graft‐versus‐host disease and graft‐versus‐tumor activity. Immunological Reviews 258:1, pages 30-44.
Crossref
Crossref
Mohammed S Inayat, Ismail S El-Amouri, Mohammad Bani-Ahmad, Howard L Elford, Vincent S Gallicchio & Oliver R Oakley. (2010) Inhibition of allogeneic inflammatory responses by the Ribonucleotide Reductase Inhibitors, Didox and Trimidox. Journal of Inflammation 7:1.
Crossref
Crossref
Ying Lu & Edmund K. Waller. (2009) Dichotomous Role of Interferon-γ in Allogeneic Bone Marrow Transplant. Biology of Blood and Marrow Transplantation 15:11, pages 1347-1353.
Crossref
Crossref
Kenneth B. DeSantes & Paul M. Sondel. 2009. Oncology of Infancy and Childhood. Oncology of Infancy and Childhood
209
240
.
Thea M. Friedman, Kira GoldgirshStephanie A. BergerJenny ZilberbergJoanne Filicko-O'Hara, Neal Flomenberg, Michele DonatoScott D. RowleyRobert Korngold. (2008) Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vβ use: a new paradigm for designer allogeneic blood and marrow transplantation. Blood 112:8, pages 3517-3525.
Crossref
Crossref
M. Har-Noy & S. Slavin. (2008) The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement?. Medical Hypotheses 70:6, pages 1186-1192.
Crossref
Crossref
Masayuki Nagasawa, Takeshi Isoda, Sukeyuki Itoh, Michiko Kajiwara, Tomohiro Morio, Norio Shimizu, Kazuyuki Ogawa, Kinya Nagata, Masataka Nakamura & Shuki Mizutani. (2006) Analysis of serum granulysin in patients with hematopoietic stem‐cell transplantation: Its usefulness as a marker of graft‐versus‐host reaction. American Journal of Hematology 81:5, pages 340-348.
Crossref
Crossref
Amar Safdar, Gilhen Rodriguez, Norio Ohmagari, Dimitrios P. Kontoyiannis, Kenneth V. Rolston, Issam I. Raad & Richard E. Champlin. (2005) The safety of interferon‐γ‐1b therapy for invasive fungal infections after hematopoietic stem cell transplantation. Cancer 103:4, pages 731-739.
Crossref
Crossref
Jeffrey Molldrem & Warren Shlomchik. 2004. Graft vs. Host Disease, Third Edition. Graft vs. Host Disease, Third Edition
155
194
.
Robert Korngold, Thea Friedman & Stephen Jones. 2004. Graft vs. Host Disease, Third Edition. Graft vs. Host Disease, Third Edition
35
58
.
Robert L. Truitt. (2004) The Mortimer M. Bortin lecture. Biology of Blood and Marrow Transplantation 10:8, pages 505-523.
Crossref
Crossref
Megan Sykes. 2003. Thomas' Hematopoietic Cell Transplantation. Thomas' Hematopoietic Cell Transplantation
300
323
.
Pavan Reddy & James L.M Ferrara. (2003) Immunobiology of acute graft-versus-host disease. Blood Reviews 17:4, pages 187-194.
Crossref
Crossref
Pavan Reddy. (2003) Pathophysiology of acute graft‐versus‐host disease. Hematological Oncology 21:4, pages 149-161.
Crossref
Crossref
Britt E. Anderson, Jennifer McNiff, Jun Yan, Hester Doyle, Mark Mamula, Mark J. Shlomchik & Warren D. Shlomchik. (2003) Memory CD4+ T cells do not induce graft-versus-host disease. Journal of Clinical Investigation 112:1, pages 101-108.
Crossref
Crossref
Pavan Reddy & James L.M Ferrara. (2003) Role of interleukin-18 in acute graft-vs-host disease. Journal of Laboratory and Clinical Medicine 141:6, pages 365-371.
Crossref
Crossref
Pavan ReddyTakanori TeshimaGerhard HildebrandtDebra L. WilliamsChen LiuKenneth R. CookeJames L.M. Ferrara. (2003) Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects. Blood 101:7, pages 2877-2885.
Crossref
Crossref
Stephen C. Jones, George F. Murphy & Robert Korngold. (2003) Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia response. Biology of Blood and Marrow Transplantation 9:4, pages 243-256.
Crossref
Crossref
Jinli LiuBritt E. AndersonMarie E. RobertJennifer M. McNiffStephen G. EmersonWarren D. ShlomchikMark J. Shlomchik. (2001) Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease. Blood 98:12, pages 3367-3375.
Crossref
Crossref
H. Joachim Deeg. (2018) Cytokines in Graft-Versus-Host Disease and the Graft-Versus-Leukemia Reaction. International Journal of Hematology 74:1, pages 26-32.
Crossref
Crossref